Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Estriol Vaginal Gel in HR+ Breast Cancer Patients on Aromatase Inhibitors
NCT02413008Phase 2Completed
- Sponsor
- ITF Research Pharma
- Start
- Oct 2015
- Primary completion
- Feb 2017
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of estriol in vaginal atrophy, sponsored by ITF Research Pharma. Started Oct 2015; status: completed.
02
Drugs
estriol
03
Conditions
vaginal atrophy
Beyond the preview
Go deeper on NCT02413008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02413008.